Skip to main content

. 1987 Oct;56(4):509–530. doi: 10.1038/bjc.1987.235

Advances in the applications of monoclonal antibodies in clinical oncology. London, 6-8 May 1987. Abstracts.

PMCID: PMC2001817 PMID: 3689668

512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Delaloye B., Bischof-Delaloye A., Buchegger F., von Fliedner V., Grob J. P., Volant J. C., Pettavel J., Mach J. P. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest. 1986 Jan;77(1):301–311. doi: 10.1172/JCI112291. [DOI] [PMC free article] [PubMed] [Google Scholar]
Glassy M. C., Handley H. H., Hagiwara H., Royston I. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6327–6331. doi: 10.1073/pnas.80.20.6327. [DOI] [PMC free article] [PubMed] [Google Scholar]
Neuberger M. S., Williams G. T., Mitchell E. B., Jouhal S. S., Flanagan J. G., Rabbitts T. H. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature. 1985 Mar 21;314(6008):268–270. doi: 10.1038/314268a0. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES